| 发明名称 |
(11SS,17SS)-17-HYDROXY-11-[4-(METHYLSULPHONYL)PHENYL]-17-(PENTAFLUORO- ETHYL)ESTRA-4,9-DIEN-3-ONE FOR THE TREATMENT OF CHARCOT MARIE TOOTH DISEASE |
| 摘要 |
The invention relates to the treatment of Charcot Marie tooth disease with the progesterone receptor antagonist (11beta,17beta)-17-hydroxy-11-[4- (methylsulphonyl)phenyl]-17-(pentafluoroethyl)estra-4,9-dien-3-one and its pharmaceutically compatible salts. |
| 申请公布号 |
WO2013087575(A1) |
申请公布日期 |
2013.06.20 |
| 申请号 |
WO2012EP74972 |
申请日期 |
2012.12.10 |
| 申请人 |
BAYER INTELLECTUAL PROPERTY GMBH |
发明人 |
GOTTWALD, ULRICH;WAGENFELD, ANDREA;ROTTMANN, ANTJE |
| 分类号 |
A61K31/57;A61P25/02 |
主分类号 |
A61K31/57 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
